Year: 2024
Type: article
Abstract: Exempting pharmacy orders of buprenorphine from investigative reports and eliminating prior authorization requirements for the medication are among the significant recommendations offered in an opinion piece calling for expanded access to the treatment.
Source: Alcoholism & Drug Abuse Weekly
DOI: 10.1002/adaw.34350
Author: Gary Enos
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4405369598